close Icon
Rectangle 55 (6)
  1. Home
  2. Knowledge and Media
  3. Research Reports + Policy Briefs
  4. A promising start to introduction of new hepatitis C treatment for HIV-infected populations across the world

A promising start to introduction of new hepatitis C treatment for HIV-infected populations across the world

Real-world data from six countries show promising early outcomes of direct-acting antiviral treatment for people co-infected with HIV and hepatitis C.

Download Report
Square Rachel Sacks Davis Web

Rachel Sacks-Davis

Dr Rachel Sacks-Davis is a Senior Research Officer at the Burnet Institute in the Disease Elimination Program. She is the Senior Manager of the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC).

EMAIL Call